K2 Principal Fund, L.P. Bausch Health Companies Inc. Transaction History

K2 Principal Fund, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$23.0 - $29.01 $1.66 Million - $2.09 Million	72,038 Added 643.2%	83,238 $2.3 Million
Q2 2021 Aug 13, 2021	SELL	$27.43 - $32.7 $3.62 Million - $4.32 Million	-132,071 Reduced 92.18%	11,200 $328,000
Q3 2020 Nov 13, 2020	BUY	$14.88 - $20.13 $2.13 Million - $2.88 Million	143,271 New	143,271 $2.23 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.